BS Identity and Score for QULIPTA (AbbVie)

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: QULIPTA (AbbVie) (qulipta.com)

https://qulipta.com 📍 Industry: Medical Devices, Pharma & Biotech
23 BS / 100

This site is a textbook example of high-substance pharmaceutical marketing: it utilizes trademarked emotional fluff in headings to capture attention but provides mandatory, forensic evidence in the body to satisfy regulators. It is low on bullshit because the cost of lying in this industry is legal catastrophe.

Info Density Power-words vs. Substance ratio.
12
40% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
3
15% BS
Commodity Fingerprint Detection of industry clichés/templates.
6
40% BS
Identity & Authority Expert verifiability & Schema depth.
2
13% BS

Convert emotional H2 headings like THE FORGET-YOU-GET-MIGRAINE MEDICINE into substance-led headings that cite the actual reduction in migraine days found in the trials. Replace generic CTAs like READY TO TAKE THE NEXT STEP with more specific technical paths like REVIEW THE CLINICAL TRIAL DATA. Provide a direct link to the ClinicalTrials.gov registration number instead of just internal PDFs to improve transparency. Reduce the three-fold repetition of the zero-migraine-day value prop across sub-pages to increase unique information density.

Info Density Power-words vs. Substance ratio.
12 Impact Weight: 30 / 100
40% BS

The Information Density is split between highly fluffy headings and high-substance body text. Headings like THE FORGET-YOU-GET-MIGRAINE MEDICINE and READY TO TAKE THE NEXT STEP are pure marketing fluff, scoring high on fluff saturation. However, the body text provides specific clinical trial results, such as nausea rates of 5-9 percent versus 3 percent for placebo, which effectively anchors the claims in technical reality.

If your primary content isn't server side, your site collapses into an empty shell for every LLM. Check your server side content exposure and confirm whether AI can extract anything meaningful at all.

Semantic Coherence Homepage promise vs. Sub-page reality.
0 Impact Weight: 20 / 100
0% BS

Semantic Drift is nearly non-existent. The homepage H1 MORE ZERO-MIGRAINEDAYS ARE POSSIBLE is directly supported by the Why Qulipta sub-page, which details the 3-month studies and the mechanism of action involving CGRP receptor blocking. There is no disconnect between the hero promise and the technical delivery described on deeper pages.

Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.

Trust & Proof Verifiable evidence vs. Trust Theatre.
3 Impact Weight: 20 / 100
15% BS

The site avoids typical trust theatre like unverified star ratings, which are often prohibited in pharma marketing. Instead, it uses a patient testimonial from ‘Kelsi’ with a mandatory disclosure that she was compensated, which is a regulatory honesty marker. The review_count is 0 across all pages, but the presence of two verified proof links to full prescribing information provides high-substance validation.

The proof density is high for the pharma industry. Verifiable evidence includes specific side effect percentages (constipation 6-8 percent), dose availability (10 mg, 30 mg, 60 mg), and trial duration (3-month studies). For every vague assertion of ‘more zero-migraine days,’ there is a corresponding technical specification in the body text or the Important Safety Information block.

For a concrete demonstration of how the methodology exposes structural, semantic, and commercial gaps in a real hospitality brand, review a full executive level diagnostic applied to a coastal 4 star resort. View the Connemara Coast Hotel Executive SEO Strategy to see how positioning drift, UX friction, and experience SEO failures are surfaced in practice.

Commodity Fingerprint Detection of industry clichés/templates.
6 Impact Weight: 15 / 100
40% BS

The site exhibits a Moderate Commodity Fingerprint due to standard pharmaceutical marketing templates. Phrases like ‘Savings and Support Made Simple’ and ‘Want to learn more?’ are generic value proposition cliches. The template fingerprint for patient resources and doctor discussion guides is a industry-wide standard, making the structure indistinguishable from other drug landing pages.

Identity & Authority Expert verifiability & Schema depth.
2 Impact Weight: 15 / 100
13% BS

Authority is well-established through AbbVie’s corporate identity and proper schema_json implementation. The use of MedicalWebPage and Drug schema with sameAs links to Wikipedia for Atogepant provides a verifiable digital footprint. The only minor gap is the reliance on a single named patient (Kelsi) without a professional digital footprint for other ‘experts’ beyond the corporate entity.

There is a minor disconnect between the emotional marketing claim of ‘forgetting’ you have migraines and the clinical data which merely shows a reduction in migraine days. However, the site uses mandatory qualifiers like ‘Individual results may vary’ and ‘You will never truly forget migraine’ to bridge the gap between marketing tone and medical reality.

Medical Devices, Pharma & Biotech BS: QULIPTA (AbbVie) (qulipta.com)

BS: 23/ 100

The site content perfectly aligns with the Medical and Pharma category, adhering to strict regulatory requirements for ‘Important Safety Information’ and clinical data presentation. The use of specific active ingredients like Atogepant and CGRP terminology confirms a high-fidelity industry match.

If your entity graph is unstable, every other part of the framework inherits that instability. Study the Structured Data Framework Guide and see why schema is not markup — it is the machine readable definition of your domain.

“The score of 23 is driven primarily by the Commodity Fingerprint and Information Density pillars. While the site is legally required to be factual, it relies heavily on trademarked slogans and generic pharmaceutical marketing templates. The high substance of the clinical data prevents the score from reaching a moderate or high BS level.”

To understand and learn thinking like AI, visit our educational environment (QULIPTA (AbbVie) example) that uses the same data this audit was generated from, and try it yourself.
Verified Analysis Date: June 19, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY